Does haemophilia influence cancer-related mortality in HIV-negative patients?

作者: W. MIESBACH , E. SEIFRIED

DOI: 10.1111/J.1365-2516.2010.02364.X

关键词: MedicineLiver diseaseVirologyCoagulation Factor DeficiencyHaemophiliaHepatitis C virusCancerHepatocellular carcinomaOncologyEpidemiologyInternal medicinePopulation

摘要: Summary.  Clinical investigations and animal studies suggest haemophilia specific effects on cancer-related mortality aside from virus induced malignancies. Analysis of results in the literature proposes that coagulation factor deficiency might inhibit cancer metastasis through decreased activation thrombin. On other hand, substitution increase rates. A review epidemiological was conducted to survey clinical data concerning always deal with virus-related malignancies caused by HIV and/or hepatitis C (HCV) infections. Therefore, analysis rates standardized ratios (SMR) under exclusion infection concomitant like non-Hodgkin-lymphomas HCV-related deaths liver disease hepatocellular carcinoma. The covers which report causes more than 8000 patients, including 2700 HIV-negative patients. Results show independent 8–16% deaths. corresponding SMRs supports hypothesis rates, unaffected or hepatoma, are when compared general population. Prospective collection regarding consumption as well severity negative patients is needed investigate interaction between cancer.

参考文章(36)
Philip S. Rosenberg, Kenneth E. Sherman, Angelos Hatzakis, Michael M. Lederman, Louis M. Aledort, Margaret W. Hilgartner, Gilbert C. White, Titica Mandalaki, Marilyn Manco-Johnson, Liliana Preiss, Barbara L. Kroner, Cindy Leissinger, Alan R. Cohen, Craig M. Kessler, Naomi L. C. Luban, Donna DiMichele, Anne L. Angiolillo, James J. Goedert, Philippe de Moerloose, M. Elaine Eyster, End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood. ,vol. 100, pp. 1584- 1589 ,(2002) , 10.1182/BLOOD.V100.5.1584.H81702001584_1584_1589
Emmanuil Koumbarelis, Frits R Rosendaal, Argyri Gialeraki, Anastasia Karafoulidou, Willy M P Noteboom, Calliopi Loizou, Catherine Panayotopoulou, Constantine Markakis, Titica Mandalaki, Epidemiology of haemophilia in Greece: an overview Thrombosis and Haemostasis. ,vol. 72, pp. 808- 813 ,(1994) , 10.1055/S-0038-1648966
Mattanja Triemstra, Frits R Rosendaal, Cees Smit, Henk M Van der Ploeg, Ernest Briet, Mortality in Patients with Hemophilia: Changes in a Dutch Population from 1986 to 1992 and 1973 to 1986 Annals of Internal Medicine. ,vol. 123, pp. 823- 827 ,(1995) , 10.7326/0003-4819-123-11-199512010-00002
R.A. Coutinho, o.m. AMC-werkgroeplid, Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults Journal of the National Cancer Institute. ,vol. 92, pp. 1823- 1830 ,(2000)
Massimo Franchini, Pier Mannuccio Mannucci, Co‐morbidities and quality of life in elderly persons with haemophilia British Journal of Haematology. ,vol. 148, pp. 522- 533 ,(2010) , 10.1111/J.1365-2141.2009.08005.X
I. R. Walker, J. A. Julian, , Causes of death in Canadians with haemophilia 1980–1995 Haemophilia. ,vol. 4, pp. 714- 720 ,(1998) , 10.1046/J.1365-2516.1998.00179.X
M. Makris, F.E. Preston, D.R. Triger, J.C.E. Underwood, Q.L. Choo, G. Kuo, M. Houghton, Hepatitis C antibody and chronic liver disease in haemophilia The Lancet. ,vol. 335, pp. 1117- 1119 ,(1990) , 10.1016/0140-6736(90)91124-S
Massimo Franchini, Hepatitis C in haemophiliacs. Thrombosis and Haemostasis. ,vol. 92, pp. 1259- 1268 ,(2004) , 10.1160/TH04-08-0510
Massimo Franchini, Giuseppe Lippi, Martina Montagnana, Giovanni Targher, Marco Zaffanello, Gian Luca Salvagno, Gianna Franca Rivolta, Caterina Di Perna, Annarita Tagliaferri, Hemophilia and cancer: A new challenge for hemophilia centers Cancer Treatment Reviews. ,vol. 35, pp. 374- 377 ,(2009) , 10.1016/J.CTRV.2009.01.001